topic0
Tumour NOS [neop] 0.00545434336274
HCV [virs] 0.00509406286433
Chronic hepatitis C [dsyn] 0.00328396326789
Treated [ftcn] 0.00332028882401
Higher [qlco] 0.00238953062362
Groups [idcn] 0.00370379163022
Survival [acty] 0.00352340069146
Group [idcn] 0.00565136647829
resection [topp] 0.00326601013532
HEPATITIS C VIRUS [virs] 0.00649990646622
Important [qlco] 0.00297564735061
Hepatic [blor] 0.00418459469201
HEPATITIS B VIRUS [virs] 0.00409989277833
DIAGNOSIS [fndg] 0.00331012766356
LOCAL [spco] 0.00292652895099
Study [mnob] 0.00964228580402
Mortality [qnco] 0.00569284999028
Independent [idcn] 0.0026710069732
LIVER CIRRHOSIS [dsyn] 0.00512275823807
Methods [inpr] 0.00541026604145
Compared [acty] 0.00466124185832
Hepatitis C virus infection [dsyn] 0.00410521638959
Cases [ftcn] 0.0089660310436
Equal [qlco] 0.00270405637009
YEARS [tmco] 0.0107328205269
therapy [ftcn] 0.00490464661723
CANCER [neop] 0.0029242658949
Relative Risk [qnco] 0.00388993589722
YEAR [tmco] 0.00544371664578
LIVER [bpoc] 0.00781836072276
Conclusions [idcn] 0.00394002216547
Related [qlco] 0.0075018330827
Genotype [orga] 0.00288203013661
treatment [ftcn] 0.00449750044544
CIRRHOSIS [dsyn] 0.013942823069
Liver Cancer [neop] 0.00418849868091
Risk Factors [qnco] 0.0110369934644
Tumors [neop] 0.00335104752232
Increased [qnco] 0.00405028638567
HCC [neop] 0.00287724100305
topic1
Satellite [spco] 0.00378265642026
Tumour NOS [neop] 0.00887737785186
Morbidity [qnco] 0.00302996700632
Higher [qlco] 0.00314442795604
Groups [idcn] 0.00374906214998
Survival [acty] 0.00362819783168
Group [idcn] 0.00744345187289
resection [topp] 0.00608836737559
CHOLANGITIS, PRIMARY SCLEROSING [dsyn] 0.00328552361114
SMALL [qnco] 0.00342341640268
lesions [fndg] 0.00639467915608
Hepatic [blor] 0.00321781208941
Screening [hlca] 0.00263845784445
Hepatectomy [topp] 0.00320400023939
Performed [ftcn] 0.0036233531857
TYPE [qlco] 0.00417290738087
DIAGNOSIS [fndg] 0.00302013691917
Nodular [qlco] 0.00306602907287
Study [mnob] 0.00766671189115
Mortality [qnco] 0.00444831580156
Conclusions [idcn] 0.00319451780483
Low [qlco] 0.00276668309989
Methods [inpr] 0.00388813447885
Risk Factors [qnco] 0.00540335349978
Cases [ftcn] 0.00717435638289
Hepatocellular Carcinomas [neop] 0.00267338552625
YEARS [tmco] 0.00475729401995
Mutations [genf] 0.00300056092269
Cholangiocarcinoma [neop] 0.00304632040073
LIVER [bpoc] 0.00470130099882
Related [qlco] 0.00444902291384
MR [gngm] 0.00273120909001
treatment [ftcn] 0.00544123516029
CIRRHOSIS [dsyn] 0.00289701539383
Increased [qnco] 0.00303954288753
Compared [acty] 0.00351368768142
Pathology [bmod] 0.00340619127491
Tumors [neop] 0.00400267070377
Single [popg] 0.00315572699927
HCC [neop] 0.00257042244621
topic2
Tumour NOS [neop] 0.00723200785015
Compared [acty] 0.00276410177057
Suggest [idcn] 0.00308282120643
Treated [ftcn] 0.00283419989605
Present [qnco] 0.00272275949439
Survival [acty] 0.00453016200051
resection [topp] 0.00526520039466
Including [ftcn] 0.00296644149362
HEPATITIS C VIRUS [virs] 0.00414412306892
Liver Cancer [neop] 0.00267006510771
HEPATITIS B VIRUS [virs] 0.00536015681674
DIAGNOSIS [fndg] 0.00404566124093
Study [mnob] 0.0065663273939
control [qlco] 0.00294580896201
Independent [idcn] 0.00318364313034
Conclusions [idcn] 0.00407607610579
Exposure NOS [inpo] 0.00347699679481
Methods [inpr] 0.00466695702817
CANCER [neop] 0.00321068429309
Hepatitis C virus infection [dsyn] 0.00264525217414
Cases [ftcn] 0.00877209034867
YEARS [tmco] 0.00595801438659
Mutations [genf] 0.00247912892431
Human [humn] 0.00274965999384
Liver Transplantation [topp] 0.00303357590695
YEAR [tmco] 0.00286705557946
LIVER [bpoc] 0.00772615187396
2000s [tmco] 0.00294997578021
Related [qlco] 0.00410021478702
CURRENT [tmco] 0.00279291441069
Odds Ratio [qnco] 0.00564423375522
treatment [ftcn] 0.00630170312675
CIRRHOSIS [dsyn] 0.00393757491882
Aflatoxin [hops] 0.00284365980493
Levels [qlco] 0.00652731621712
Primary liver cancer [neop] 0.00267431920084
Risk Factors [qnco] 0.00948608840454
Tumors [neop] 0.00429484812005
Increased [qnco] 0.00336042984276
HCC [neop] 0.00302601468979
topic3
Tumour NOS [neop] 0.00250285392569
Important [qlco] 0.0038559519831
Case-Control Study [resa] 0.0025832012652
DIAGNOSIS [fndg] 0.00250046196917
Present [qnco] 0.00281522439383
Survival [acty] 0.00801444322821
Group [idcn] 0.00477926974013
resection [topp] 0.00278162528035
Detection [topp] 0.00230766764787
HEPATITIS C VIRUS [virs] 0.00958879017024
lesions [fndg] 0.00381930243156
Hepatic [blor] 0.00253843728416
Association [menp] 0.0023086324003
HEPATITIS B VIRUS [virs] 0.00372264197487
Independent [idcn] 0.0028563204965
DIABETIC [fndg] 0.00268143508859
Study [mnob] 0.0100004939105
control [qlco] 0.00358187176682
Suggest [idcn] 0.00251147618099
Conclusions [idcn] 0.00297926098019
Methods [inpr] 0.00464878249932
Compared [acty] 0.00330101158526
Hepatitis C virus infection [dsyn] 0.00243219032364
Cases [ftcn] 0.0057609644892
YEARS [tmco] 0.00442685664572
HEPATITIS B [dsyn] 0.00248817842278
YEAR [tmco] 0.00229753179041
LIVER [bpoc] 0.0146621211431
Related [qlco] 0.00297295979149
Hepatitis C [dsyn] 0.00323742412299
Evaluate [hlca] 0.00227753443696
Identified [qlco] 0.00261522424176
treatment [ftcn] 0.00869688933587
CIRRHOSIS [dsyn] 0.00504828661717
Liver Cancer [neop] 0.00348342685178
Risk Factors [qnco] 0.00814396521652
Pathology [bmod] 0.0041329623714
Tumors [neop] 0.00257618141235
Increased [qnco] 0.00408086017262
NEW [qlco] 0.00293971332423
topic4
Tumour NOS [neop] 0.00309321427185
HCV [virs] 0.00822170887097
Disease-Free Survival [qnco] 0.00287380999272
Survival [acty] 0.00415004219904
Group [idcn] 0.00640490736524
resection [topp] 0.00594928674248
HEPATITIS C VIRUS [virs] 0.00840666033965
HEPATITIS [dsyn] 0.00258717457063
Important [qlco] 0.00359154177203
Nodules [acab] 0.0030310168446
Hepatic [blor] 0.00264665165239
LIVER [bpoc] 0.00746415036097
HEPATITIS B VIRUS [virs] 0.00568105713005
SERUM [bdsu] 0.00409652170652
Independent [idcn] 0.00370130412298
Study [mnob] 0.00724757605344
control [qlco] 0.00598530666246
Suggest [idcn] 0.00295810842699
Conclusions [idcn] 0.0033858572381
Methods [inpr] 0.00437543155547
Compared [acty] 0.003002342694
Cases [ftcn] 0.00791036421005
2000s [tmco] 0.00276555999998
YEARS [tmco] 0.00401616798187
Science [ocdi] 0.00284783784624
YEAR [tmco] 0.00672308308405
Hepatectomy [topp] 0.00449363431628
Chronic hepatitis C [dsyn] 0.00276866735208
Related [qlco] 0.00368687556746
Activity [ftcn] 0.00264706236629
Postoperative [tmco] 0.00424456197682
treatment [ftcn] 0.00264953770441
CIRRHOSIS [dsyn] 0.00620151423508
Cirrhotic [qlco] 0.00327222803102
Levels [qlco] 0.00329249348475
Risk Factors [qnco] 0.0128526646268
Association [menp] 0.00272594573455
CANCER [neop] 0.00260062715548
Increased [qnco] 0.00372720106837
HCC [neop] 0.00290984410682
topic5
Tumour NOS [neop] 0.0048184117449
Disease-Free Survival [qnco] 0.00266154211434
Treated [ftcn] 0.00258149968527
Higher [qlco] 0.00449347154517
bile leakage [patf] 0.0029622078418
Survival [acty] 0.00593982689081
Group [idcn] 0.00252907188976
resection [topp] 0.00896742189403
HEPATITIS C VIRUS [virs] 0.00355366901484
lesions [fndg] 0.0029201871644
Intrahepatic [spco] 0.00399440684845
Hepatic [blor] 0.0116949798243
LIVER [bpoc] 0.00873257635505
Performed [ftcn] 0.0027364639401
HEPATITIS B VIRUS [virs] 0.00264162108786
Study [mnob] 0.0060318298091
control [qlco] 0.00325147494143
2000s [tmco] 0.00236754958102
Methods [inpr] 0.0042397909307
Risk Factors [qnco] 0.00526435803827
Hepatitis C virus infection [dsyn] 0.00270600561208
Cases [ftcn] 0.00433813079218
Loss [qnco] 0.00240848686309
YEARS [tmco] 0.00382828369493
Mutations [genf] 0.00337628063483
Contrast [irda] 0.00306141700626
LOWER [spco] 0.0025879769504
Hepatectomy [topp] 0.00313375796278
Related [qlco] 0.0032943062181
Genotype [orga] 0.00945542983889
Identified [qlco] 0.00355244827717
Region [geoa] 0.00310328613376
treatment [ftcn] 0.00276401849798
CIRRHOSIS [dsyn] 0.00439189784881
Genotypes [orga] 0.00266124704861
Compared [acty] 0.00403241141359
Pathology [bmod] 0.00245588650641
CARCINOMA [neop] 0.00259609550235
Tumors [neop] 0.00302905838465
Increased [qnco] 0.00303953844126
topic6
Tumour NOS [neop] 0.00585218728884
HCV [virs] 0.00448611565915
Treated [ftcn] 0.00364296378115
Higher [qlco] 0.00356975614147
Present [qnco] 0.00306786607551
Survival [acty] 0.00639294951413
Group [idcn] 0.00493239427985
resection [topp] 0.00635426320271
CHOLANGITIS, PRIMARY SCLEROSING [dsyn] 0.00280779614462
HEPATITIS C VIRUS [virs] 0.0100924168616
lesions [fndg] 0.00335649645791
Intrahepatic [spco] 0.00391580249259
Hepatic [blor] 0.00666522922385
Association [menp] 0.00316798293462
SERUM [bdsu] 0.00355919694903
Suggest [idcn] 0.00299083529865
HCCS [gngm] 0.00343065991195
Study [mnob] 0.00925221118562
LOWER [spco] 0.00346676761139
Independent [idcn] 0.00281015635966
LIVER CIRRHOSIS [dsyn] 0.00370209857498
Methods [inpr] 0.00607474841015
Hepatitis C virus infection [dsyn] 0.0039260703192
Cases [ftcn] 0.00495756236669
Radiofrequency Ablation [topp] 0.003075542922
YEARS [tmco] 0.00725849703182
control [qlco] 0.00336847633712
Cholangiocarcinoma [neop] 0.00377591584681
YEAR [tmco] 0.00372589902034
LIVER [bpoc] 0.00645401405851
Conclusions [idcn] 0.0045139290746
Related [qlco] 0.00351915042472
Identified [qlco] 0.0027728268513
treatment [ftcn] 0.00344661318203
CIRRHOSIS [dsyn] 0.00388205807044
Cirrhotic [qlco] 0.00342865406414
Levels [qlco] 0.00584027313809
Risk Factors [qnco] 0.00711706470174
Pathology [bmod] 0.00334930088024
Tumors [neop] 0.00392465820212
topic7
Tumour NOS [neop] 0.00327845201913
HCV [virs] 0.00374357406172
Treated [ftcn] 0.00289168128143
Survival [acty] 0.00648023263415
resection [topp] 0.00885441183284
HEPATITIS C VIRUS [virs] 0.00306111225632
free [ftcn] 0.00300790790025
carriers [fndg] 0.00276473097353
Hepatic [blor] 0.00594862706806
Hepatocellular Carcinomas [neop] 0.00432144483795
Observed [ftcn] 0.00304876687612
DIAGNOSIS [fndg] 0.00303194268525
Study [mnob] 0.00544503823877
control [qlco] 0.00530910160568
Suggest [idcn] 0.0026855384021
LIVER CIRRHOSIS [dsyn] 0.00398996479014
Methods [inpr] 0.00462543115853
Risk Factors [qnco] 0.00563916004768
Hepatitis C virus infection [dsyn] 0.00332451203739
Cases [ftcn] 0.00428647651005
Stage [tmco] 0.00267963383134
YEARS [tmco] 0.0135801818271
LOWER [spco] 0.00317198359247
Women [popg] 0.0045986608492
Liver Transplantation [topp] 0.00323534192745
Human [humn] 0.00294250442772
YEAR [tmco] 0.00500108313294
LIVER [bpoc] 0.00850971607579
Conclusions [idcn] 0.00444309715628
Related [qlco] 0.00394351005283
Genotype [orga] 0.00361602723732
MALE [orga] 0.00302464069502
Progression [patf] 0.00301354097588
Odds Ratio [qnco] 0.00298301529038
treatment [ftcn] 0.00474327869478
CIRRHOSIS [dsyn] 0.0137864962947
Transplantation [topp] 0.00504620212752
Cirrhotic [qlco] 0.0054056918138
Compared [acty] 0.00498906626385
HEPATITIS B [dsyn] 0.00336720417831
topic8
Tumour NOS [neop] 0.00441271752774
Treated [ftcn] 0.00416796303556
Higher [qlco] 0.00265581145273
Present [qnco] 0.00305136877809
Groups [idcn] 0.00248981610132
Survival [acty] 0.0051376663522
Group [idcn] 0.00502700654006
resection [topp] 0.00310576870652
CHOLANGITIS, PRIMARY SCLEROSING [dsyn] 0.00315488460933
HEPATITIS C VIRUS [virs] 0.0109326233909
Hepatic [blor] 0.0053075009461
Performed [ftcn] 0.00259247589379
variables [qlco] 0.00254804803337
DIAGNOSIS [fndg] 0.00287731883149
Study [mnob] 0.00644304561176
Mortality [qnco] 0.00275163346067
Suggest [idcn] 0.00266598153655
Conclusions [idcn] 0.0042488498153
Methods [inpr] 0.00490413826298
Compared [acty] 0.00347199391211
Hepatitis C virus infection [dsyn] 0.00493614676591
Cases [ftcn] 0.0122410852353
YEARS [tmco] 0.0072088985831
HEPATITIS B [dsyn] 0.00266956259918
control [qlco] 0.00273614186329
Cholangiocarcinoma [neop] 0.00861088743706
DEATH [orgf] 0.00264214203884
YEAR [tmco] 0.0100068299136
LIVER [bpoc] 0.00485121978824
LIVER CIRRHOSIS [dsyn] 0.00458405787874
Related [qlco] 0.00833948007135
Diagnosed [fndg] 0.00277212586341
treatment [ftcn] 0.00616509073419
CIRRHOSIS [dsyn] 0.010101605965
FIBROSIS [patf] 0.00281944326527
Cirrhotic [qlco] 0.00443001950997
Levels [qlco] 0.00367786744002
Risk Factors [qnco] 0.00949458782359
Increased [qnco] 0.00292177361855
HCC [neop] 0.00266112805147
topic9
Tumour NOS [neop] 0.00611485140442
Significantly high [qnco] 0.00269645758678
Treated [ftcn] 0.00238351454958
Present [qnco] 0.00233520440148
Groups [idcn] 0.00284606376965
Survival [acty] 0.00230452520851
resection [topp] 0.00513219621812
Phase [tmco] 0.00254083327969
Including [ftcn] 0.0024638824293
HEPATITIS C VIRUS [virs] 0.00676776619621
lesions [fndg] 0.00325544741418
TYPE [qlco] 0.00281466414895
Hepatic [blor] 0.00423248194046
Observed [ftcn] 0.00336166941338
SERUM [bdsu] 0.00272228337171
Suggest [idcn] 0.00245685058536
Study [mnob] 0.00828737635888
Response [orga] 0.00386026525918
Chronic hepatitis C [dsyn] 0.00611567054447
Methods [inpr] 0.00267567783623
Compared [acty] 0.00315221200254
Hepatitis C virus infection [dsyn] 0.00350818490415
Cases [ftcn] 0.00578970898454
Computed Tomography [diap] 0.00248000177078
YEARS [tmco] 0.00454680123987
Human [humn] 0.00326357403765
therapy [ftcn] 0.00422057364665
LIVER [bpoc] 0.0176982165816
Conclusions [idcn] 0.00381794143653
Related [qlco] 0.00343154278821
treatment [ftcn] 0.00418668590652
CIRRHOSIS [dsyn] 0.00509504015244
Cirrhotic [qlco] 0.0025671889169
Detected [fndg] 0.00458666877644
Risk Factors [qnco] 0.00570594942467
Pathology [bmod] 0.00291279312679
Sera [bdsu] 0.00229999398405
Tumors [neop] 0.00312250108378
Increased [qnco] 0.00275707840334
Interferon Therapy [topp] 0.00320260908347
